arrow
P

Peter Valent

Medical University of Vienna
H指数:131
被引数:7.2万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatment

CDK6失活对抗CALR突变诱导的MPN演化并使MPN干细胞对干扰素-α治疗敏感

2026-05-120
PRE
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis

靶向CD117的CAR T细胞在先进系统性肥大细胞增多症的临床前模型中有效清除肥大细胞

Leukemia
IF13.4
2026-05-070
OAAI
Triterpenoid Exposure and HO-1 Blockade Sensitize Neoplastic Mast Cells Against Midostaurin and Avapritinib

三萜暴露和HO-1阻断使肿瘤性肥大细胞对米多司他汀和阿瓦普利替尼更敏感

Cells
IF5.2
2026-01-010
OA
Post-traumatic stress in cancer patients: prevalence and psychosocial correlates

癌症患者创伤后应激:患病率与心理社会相关因素

2026-01-010
OA
Diagnosis and management of patients with mast cell activation syndromes: status 2026

肥大细胞活化综合征患者的诊断与管理:2026年现状

2025-11-220
PRE
Changes in cardiac parameters during venetoclax treatment

在venetoclax治疗期间的心脏参数变化

2025-10-010
OAAI
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in new era: A CIBMTR study

异基因造血细胞移植在新时代晚期系统性肥大细胞增生症中的应用:一项CIBMTR研究

2025-09-220
PRE
Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts

健康与疾病中的组织驻留髓系和组织细胞:新兴概念

2025-09-120
PREAI
Bone marrow mastocytosis associated with primary cutaneous follicle center lymphoma: an unusual case report

骨髓肥大细胞增多症与原发性皮肤滤泡中心淋巴瘤相关:一例罕见的病例报告

2025-09-060
OAAI
A COMPARISON OF PROGNOSTIC VARIABLES AND CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED AND 4738 WITH PRIMARY MDS INCLUDING THE INFLUENCE OF TREATMENT IN MDS-PHASE

比较治疗相关和原发性MDS的1590例与4738例患者预后变量和细胞遗传学异常的比较,包括MDS阶段治疗的影响

2025-09-010
PRE
Latent structure and measurement invariance of the post-traumatic stress Scale-10 in cancer patients

创伤后应激量表-10在癌症患者中的潜在结构和测量不变性

2025-09-010
OAAI
ADH5/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implications

ADH5/ALDH2脱氢酶和DNA聚合酶theta保护正常和恶性造血细胞免受甲醛挑战:治疗意义

Leukemia
IF13.4
2025-07-100
OAAI
Evolution of Mast Cell Research Associated with the Laboratory of Allergic Diseases: 1985-2022 Presented at 2023 NIAID Symposium

与过敏性疾病实验室相关的肥大细胞研究进展:1985-2022(2023年NIAID研讨会报告)

2025-07-070
PRE
The enhanced integration of proven techniques to quantify the uncertainty of forecasting extreme flood events based on numerical weather prediction models

基于数值天气预报模型的,对极端洪水事件预测不确定性的量化中,经过验证技术的增强集成

2025-06-010
OAAI
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12

NUP98::KDM5A融合癌蛋白通过转录和表观遗传重编程直接激活CDK12

2025-05-190
OAAI
Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of disease

癌症患者中的克隆性造血及其与血栓风险和疾病预后的关联

2025-05-010
OA
Mastocytosis

肥大细胞增多症

2025-04-240
PRE
Comparing functional and genomic-based precision medicine in blood cancer patients

比较基于功能与基因组学的血液肿瘤患者精准医学

2025-04-240
OAAI
CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+leukemia
2025-02-180
OAAI
The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients
2025-02-010
OAAI